Russell Investments Group’s Gyre Therapeutics GYRE Stock Holding History

Russell Investments Group’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.9K	Buy	3,783 +2,659	+237%	+$18.1K	﹤0.01%	3775
2026 Q1	$7.83K	Sell	1,124 -879	-44%	-$6.83K	﹤0.01%	3827
2025 Q4	$14.1K	Buy	2,003 +879	+78%	+$6.78K	﹤0.01%	3710
2025 Q3	$8.38K	Buy	+1,124	New	+$8.54K	﹤0.01%	3823
2021 Q2	–	Sell	-7,129	Closed	-$269K	–	3249
2021 Q1	$269K	Sell	7,129 -418	-6%	-$19.1K	﹤0.01%	2751
2020 Q4	$356K	Buy	7,547 +7,129	+1,706%	+$309K	﹤0.01%	2558
2020 Q3	$13K	Hold	418	–	–	﹤0.01%	3148
2020 Q2	$18K	Buy	+418	New	+$19.6K	﹤0.01%	3060
2019 Q2	–	Sell	-7,185	Closed	-$437K	–	2903
2019 Q1	$437K	Buy	+7,185	New	+$462K	﹤0.01%	2391

Other funds holding GYRE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Russell Investments Group's GYRE Position: Q2 2026 in Review

Russell Investments Group increased its Gyre Therapeutics (GYRE) stake by 237% in Q2 2026, buying an estimated $18.1K and bringing the position to 3,783 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3775.

Russell Investments Group first reported a position in GYRE in Q1 2019 and has held it in 9 quarters since. The position peaked at $437K in Q1 2019. 22 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

Russell Investments Group held 3,783 shares of Gyre Therapeutics worth $24.9K as of Q2 2026.
Russell Investments Group bought 2,659 Gyre Therapeutics shares in Q2 2026, an estimated $18.1K.
Gyre Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3775 holding.
Russell Investments Group first reported a position in Gyre Therapeutics in Q1 2019 and has held it in 9 quarters since.
Russell Investments Group's Gyre Therapeutics position peaked at $437K in Q1 2019.
22 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.